The role of sublingual sufentanil nanotabs for pain relief

Harold S. Minkowitz, Keith Candiotti

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Introduction: The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil.Areas covered: This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed.Expert opinion: This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.

Original languageEnglish (US)
Pages (from-to)845-851
Number of pages7
JournalExpert Opinion on Drug Delivery
Issue number5
StatePublished - May 1 2015


  • Microtablet
  • Pain
  • Sublingual
  • Sufentanil

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'The role of sublingual sufentanil nanotabs for pain relief'. Together they form a unique fingerprint.

Cite this